Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Exelixis Inc (EXEL)  
$20.91 0.32 (1.51%) as of 4:30 Fri 5/17


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 310,240,000
Market Cap: 6.49(B)
Last Volume: 1,548,181 Avg Vol: 2,440,013
52 Week Range: $18.78 - $24.13
Level I Sector: Industrials
Level II Sector: Diversified Services
Level III Sector: Research Services

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    : 14.9
Insider 6 Months    : 16.6
Insider 3/6 Months : 32
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Exelixis is an oncology-focused biotechnology company that engages in the discovery, development and commercialization of new medicines for cancers. Co.'s products include: CABOMETYX® (cabozantinib) tablets approved for renal cell carcinoma, and for previously treated hepatocellular carcinoma; and COMETRIQ® (cabozantinib) capsules approved for progressive, metastatic medullary thyroid cancer. The other products are: COTELLIC® (cobimetinib), an inhibitor of MEK approved as part of a combination regimen to treat forms of melanoma; and MINNEBRO® (esaxerenone), an oral, non-steroidal, selective blocker of the mineralocorticoid receptor approved for the treatment of hypertension in Japan.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 190,000 310,409 310,409 310,409
Total Buy Value $3,932,734 $6,534,772 $6,534,772 $6,534,772
Total People Bought 1 1 1 1
Total Buy Transactions 1 2 2 2
Total Shares Sold 77,148 336,706 542,969 981,371
Total Sell Value $1,703,116 $7,468,007 $11,664,525 $19,365,156
Total People Sold 3 5 6 10
Total Sell Transactions 3 9 13 25
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 1421
  Page 15 of 57  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lamb Peter EVP, Scientific Strategy & CSO   •       –      –    2020-10-22 4 D $21.79 $1,155,349 D/D (53,022) 294,435     -
   Lamb Peter EVP, Scientific Strategy & CSO   •       –      –    2020-10-22 4 A $0.00 $0 D/D 213,879 347,457     -
   Hessekiel Jeffrey EVP and General Counsel   •       –      –    2020-10-21 4 AS $21.95 $872,337 D/D (39,742) 343,026 -2%     
   Hessekiel Jeffrey EVP and General Counsel   •       –      –    2020-10-21 4 OE $7.27 $288,924 D/D 39,742 382,768     -
   Senner Christopher J. EVP and CFO   •       –      –    2020-10-08 4 AS $25.00 $250,000 D/D (10,000) 127,882 -10%     
   Senner Christopher J. EVP and CFO   •       –      –    2020-10-08 4 OE $3.66 $36,600 D/D 10,000 137,882     -
   Hessekiel Jeffrey EVP and General Counsel   •       –      –    2020-09-22 4 AS $26.14 $268,144 D/D (10,258) 343,026 -11%     
   Hessekiel Jeffrey EVP and General Counsel   •       –      –    2020-09-22 4 OE $7.27 $74,576 D/D 10,258 353,284     -
   Haley Patrick J. EVP, Commercial   •       –      –    2020-09-21 4 AS $26.09 $122,101 D/D (4,680) 115,571 -13%     
   Haley Patrick J. EVP, Commercial   •       –      –    2020-09-21 4 OE $5.82 $27,238 D/D 4,680 120,251     -
   Morrissey Michael M President and CEO   •       •      –    2020-09-18 4 GD $0.00 $0 I/I 32,500 931,635     -
   Morrissey Michael M President and CEO   •       •      –    2020-09-17 4 GD $0.00 $0 I/I 25,000 964,135     -
   Morrissey Michael M President and CEO   •       •      –    2020-09-16 4 GD $0.00 $0 I/I 42,500 989,135     -
   Hessekiel Jeffrey EVP and General Counsel   •       –      –    2020-09-16 4 AS $26.11 $522,200 D/D (20,000) 343,026 -16%     
   Hessekiel Jeffrey EVP and General Counsel   •       –      –    2020-09-16 4 OE $7.27 $145,400 D/D 20,000 363,026     -
   Senner Christopher J. EVP and CFO   •       –      –    2020-09-15 4 AS $25.00 $500,000 D/D (20,000) 127,882 -11%     
   Senner Christopher J. EVP and CFO   •       –      –    2020-09-15 4 OE $3.66 $73,200 D/D 20,000 147,882     -
   Hessekiel Jeffrey EVP and General Counsel   •       –      –    2020-09-08 4 D $20.71 $3,327,393 D/D (160,666) 343,026     -
   Hessekiel Jeffrey EVP and General Counsel   •       –      –    2020-09-08 4 OE $1.90 $1,293,315 D/D 249,692 503,692     -
   Hessekiel Jeffrey EVP and General Counsel   •       –      –    2020-09-02 4 D $21.58 $28,291 D/D (1,311) 254,000     -
   Hessekiel Jeffrey EVP and General Counsel   •       –      –    2020-09-02 4 A $0.00 $0 D/D 4,998 255,311     -
   Lamb Peter EVP, Scientific Strategy & CSO   •       –      –    2020-09-02 4 D $21.58 $50,130 D/D (2,323) 133,578     -
   Lamb Peter EVP, Scientific Strategy & CSO   •       –      –    2020-09-02 4 A $0.00 $0 D/D 9,370 135,901     -
   Senner Christopher J. EVP and CFO   •       –      –    2020-09-02 4 D $21.58 $55,374 D/D (2,566) 127,882     -
   Senner Christopher J. EVP and CFO   •       –      –    2020-09-02 4 A $0.00 $0 D/D 9,745 130,448     -
  1421 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 15 of 57
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us